ENDURANT CAPITAL MANAGEMENT LP Cytokinetics, Incorporated Transaction History

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

$446,000
portfolio value

ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:

+23.31%
quarter

Cytokinetics, Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -20.17% -2.32K shares -7K $48.45 9.21K
Q2 2022 share Increase 0.00% 11.53K shares 453K $39.29 11.53K